BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/7/2020 1:54:39 AM | Browse: 1105 | Download: 2517
 |
Received |
|
2019-10-28 05:01 |
 |
Peer-Review Started |
|
2019-10-28 05:02 |
 |
First Decision by Editorial Office Director |
|
2019-11-13 04:58 |
 |
Return for Revision |
|
2019-11-13 04:58 |
 |
Revised |
|
2019-11-19 04:51 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2019-11-22 10:17 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2019-11-23 04:18 |
 |
Articles in Press |
|
2019-11-23 04:18 |
 |
Edit the Manuscript by Language Editor |
|
2019-11-30 23:51 |
 |
Typeset the Manuscript |
|
2019-12-18 02:04 |
 |
Publish the Manuscript Online |
|
2020-01-07 01:54 |
| Category |
Medicine, Research & Experimental |
| Manuscript Type |
Retrospective Study |
| Article Title |
Potential role of the compound Eucommia bone tonic granules on the patients with osteoarthritis and osteonecrosis: A retrospective study
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Cheng-Xia Hu, Ke-Yao Hu and Jian-Feng Wang |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Jian-Feng Wang, MD, Attending Doctor, Pain, Qilu Hospital of Shandong University, No. 107, Wenhua West Road, Jinan 250012, Shandong Province, China. 18714779474@163.com |
| Key Words |
Osteoarthritis; Osteonecrosis; Eucommia; Patients; Meloxicam; Drug |
| Core Tip |
Eucommia can effectively enhance the curative effect of the meloxicam, and the combination of the Eucommia and meloxicam is an effective drug for the treatment of osteoarthritis and osteonecrosis. |
| Publish Date |
2020-01-07 01:54 |
| Citation |
Hu CX, Hu KY, Wang JF. Potential role of the compound Eucommia bone tonic granules on the patients with osteoarthritis and osteonecrosis: A retrospective study. World J Clin Cases 2020; 8(1): 46-53 |
| URL |
https://www.wjgnet.com/2307-8960/full/v8/i1/46.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v8.i1.46 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.